Yahoo奇摩 網頁搜尋

搜尋結果

  1. International Nonproprietary Names. International Nonproprietary Names (INN) identify pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. The INN system is managed by the World Health Organization (WHO).

  2. 2023年10月16日 · Drug Interaction Checker. Check interactions with multiple drugs, vaccines, supplements, alcohol, food and diseases. Type a drug name in the box above to get started. Not all drugs interact, and not every interaction means you must stop taking one of your medications. Always consult your healthcare provider about how drug interactions should be ...

  3. Latest drug approvals. Bkemv (eculizumab-aeeb) - May 28, 2024. Onyda XR (clonidine hydrochloride) - May 24, 2024. Opuviz (aflibercept-yszy) - May 20, 2024. Yesafili (aflibercept-jbvf) - May 20, 2024. Imdelltra (tarlatamab-dlle) - May 16, 2024. Myhibbin (mycophenolate mofetil) - May 01, 2024. Beqvez (fidanacogene elaparvovec-dzkt) - April 26 ...

  4. AHFS DI from the American Society of Health-System Pharmacists (ASHP) is the most comprehensive source of unbiased and authoritative drug information available to health professionals today. A wholly independent staff of drug information pharmacists and other professional editorial and analytical staff thoroughly research AHFS DI content.

  5. What is dabrafenib? Dabrafenib is used alone or in combination with another medicine called trametinib ( Mekinist) to treat certain types of cancer in people who have a "BRAF" gene mutation. dabrafenib is for use in treating:

  6. 2023年6月14日 · Home. Mircera. Print. Save. Mircera. Generic name: epoetin beta and methoxy polyethylene glycol [ e-POE-e-tin-BAY-ta-meth-OX-ee-pol-ee-ETH-il-een-GLYE-kol ] Drug class: Recombinant human erythropoietins. Medically reviewed by Sophia Entringer, PharmD. Last updated on Jun 14, 2023. Uses. Warnings. Before taking. Dosage. Side effects. Interactions.